CONCLUSION: Our results show that in dialysis subjects: (1) low-density lipoproteins show a more atherogenic phenotype than in the general population; (2) high-density lipoproteins are less anti-inflammatory; (3) Lp-PLA2 could potentially be used to evaluate cardiovascular risk.
PMID: 25971848 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)